![]() |
|
|
Vol. 286, Issue 1, 489-496, July 1998
Department of Pharmacology and Therapeutics (X.-F.D., J.-F.L.,
W.-H.Z., S.C., D.R.V.),
Lady Davis Institute for Medical Research
(A.S.) and Departments of
Medicine and Physiology (S.M.), McGill
University, Montreal, Quebec, Canada; and
Ste-Justine Hospital,
Research Center (K.G.P., S.C.), Montreal, Quebec, Canada
The myocardial effects of alpha-1A adrenoceptor
(alpha-1 AR) agonists in neonatal rats are mediated by
alpha-1A AR and not by alpha-1B AR,
although both receptor subtypes are equally expressed; the functions of
alpha-1B AR are not known. Here, we report that alpha-1B ARs inhibit the activities of
alpha-1A ARs in neonatal rat myocardium so that the
inactivation of alpha-1B ARs by chloroethylclonidine (CEC) potentiated the effects of nonselective alpha-1 AR
agonist phenylephrine (PE) on myocardial protein synthesis and early
gene (c-fos and c-jun) expression. CEC
did not modify the hypertrophic effect of angiotensin II. The
potentiation of the effects of PE by CEC was associated with a
translocation of Ca++-dependent protein kinase C (PKC)
,
which did not occur in the absence of CEC. Alpha-1A
AR-selective agonist A61603 was ~1000-fold more potent than PE as a
positive inotropic agent; it caused the translocation of PKC
, which
was not affected by CEC. 5-Methylurapidil antagonized the effects of PE
and A61603, suggesting that these were mediated via
alpha-1A ARs. Alpha-1D AR antagonist BMY 7378 did not modify PE-induced translocation of PKC. CEC potentiated the
effects of PE on Ca++ transients in Fura 2-AM-loaded
dispersed cardiomyocytes, and this potentiation was prevented by
nifedipine. In whole-cell patch-clamp recordings of cultured
cardiomyocytes, CEC potentiated the effect of norepinephrine on
Ca++ channel currents, which was blocked by
5-methylurapidil. We conclude that alpha-1A ARs are
positively and alpha-1B ARs are negatively coupled to
nifedipine-sensitive Ca++ channels, possibly
via Gi protein, and this antagonistic
relationship between alpha-A AR and
alpha-1B AR in the neonatal heart might be required
physiologically for normal alpha-1 AR-mediated responses and myocardial development.
This article has been cited by other articles:
![]() |
R. Germack and J. M. Dickenson Induction of {beta}3-Adrenergic Receptor Functional Expression following Chronic Stimulation with Noradrenaline in Neonatal Rat Cardiomyocytes J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 392 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. U. Rao, H. Shiraishi, and P. J. McDermott PKC-{epsilon} regulation of extracellular signal-regulated kinase: a potential role in phenylephrine-induced cardiocyte growth Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2195 - H2203. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Israilova, T. Tanaka, F. Suzuki, S. Morishima, and I. Muramatsu Pharmacological Characterization and Cross Talk of {alpha}1A- and {alpha}1B-Adrenoceptors Coexpressed in Human Embryonic Kidney 293 Cells J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 259 - 266. [Abstract] [Full Text] |
||||
![]() |
S. A Ross, B. R Rorabaugh, D. Chalothorn, J. Yun, P. J Gonzalez-Cabrera, D. F McCune, M. T Piascik, and D. M Perez The {alpha}1B-adrenergic receptor decreases the inotropic response in the mouse Langendorff heart model Cardiovasc Res, December 1, 2003; 60(3): 598 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Gonzalez-Cabrera, R. J. Gaivin, J. Yun, S. A. Ross, R. S. Papay, D. F. McCune, B. R. Rorabaugh, and D. M. Perez Genetic Profiling of alpha 1-Adrenergic Receptor Subtypes by Oligonucleotide Microarrays: Coupling to Interleukin-6 Secretion but Differences in STAT3 Phosphorylation and gp-130 Mol. Pharmacol., May 1, 2003; 63(5): 1104 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. O. Andersen, E. Qvigstad, I. Schiander, H. Aass, J.-B. Osnes, and T. Skomedal alpha 1-AR-induced positive inotropic response in heart is dependent on myosin light chain phosphorylation Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1471 - H1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Braz, O. F. Bueno, L. J. De Windt, and J. D. Molkentin PKC{alpha} regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2) J. Cell Biol., March 4, 2002; 156(5): 905 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Leon-Velarde, M.-C. Bourin, R. Germack, K. Mohammadi, B. Crozatier, and J.-P. Richalet Differential alterations in cardiac adrenergic signaling in chronic hypoxia or norepinephrine infusion Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R274 - R281. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Wang, X.-J. Du, D. J. Autelitano, C. A. Milano, and E. A. Woodcock Adverse effects of constitutively active alpha 1B-adrenergic receptors after pressure overload in mouse hearts Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1079 - H1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. McWhinney, D. Wenham, S. Kanwal, V. Kalman, C. Hansen, and J. D. Robishaw Constitutively Active Mutants of the alpha 1a- and the alpha 1b-Adrenergic Receptor Subtypes Reveal Coupling to Different Signaling Pathways and Physiological Responses in Rat Cardiac Myocytes J. Biol. Chem., January 21, 2000; 275(3): 2087 - 2097. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Braz, O. F. Bueno, L. J. De Windt, and J. D. Molkentin PKC{alpha} regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2) J. Cell Biol., March 4, 2002; 156(5): 905 - 919. [Abstract] [Full Text] [PDF] |
||||